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Abstract: A simple and convenient method was developed for the 
introduction of 2,2,2-trifluoroethoxy group to various aromatic and 
heteroaromatic systems. The novel process utilizes aromatic 
chlorides as substrates, and tetrakis(2,2,2-trifluoroethoxy) borate salt 
as an inexpensive and readily available fluoroalkoxy source in a 
palladium-catalyzed cross coupling reaction. The power of the 
developed methodology was demonstrated in the synthesis of a 
fluorous derivative of Sildenafil. 
In the last few decades, the synthesis of organic molecules 
having fluoroalkyl groups becomes one of the most intensively 
developed fields of the organic chemistry,[ 1 ] due to the high 
interest of chemical industry.[2] Besides the wide application of 
trifluoromethylated organic compounds,[3] other small fluoroalkyl 
groups such as the 2,2,2-trifluoroethyl, can be found in 
numerous drug molecules, and agrochemicals [Scheme 1]. 
Trifluoroethyl group attached to oxygen atom can have 
beneficial effect on the metabolic stability and lipophilicity of 
biologically active aryl-alkyl ethers. Furthermore, trifluoroethyl 
group can also be considered as a relatively stable protecting 
group for alcohols[4]. 
 
Scheme 1. Examples for bioactive aryl trifluoroethyl ethers 
Modification of current pharmaceuticals[ 5 ] with fluorous 
functional groups can develop better ADME (Absorption, 
Distribution, Metabolism and Excretion) properties,[6 ] thus this 
strategy is frequently used in medicinal chemistry. This applied 
strategy explains the increasing interest for direct C-, O- and N-
fluoroalkylation, and fluoroalkoxylation reactions.[7] 
To overcome the difficulties of classical ether syntheses,[8] 
many efforts have been made recently towards the 2,2,2-
trifluoroethoxylation of aryl-halides by copper-catalyzed 
reactions,[9] granting a new approach to trifluoroethyl-aryl ethers. 
Weng and co-workers[ 10 ] developed a copper-mediated 
procedure for the transformation of various (hetero)aryl 
bromides to the corresponding trifluoroethyl ether, with good 
function group tolerance. However the reaction requires 
stoichiometric amounts of a copper-organic reagent and the 
addition of strong base. The palladium-catalyzed cross-coupling 
reaction between aryl halides and 2,2,2-trifluoroethanol (TFE) in 
the presence of Cs2CO3 base were also developed, but in 
general electron-deficient, highly activated aryl-halides (mostly 
bromides) are the applicable substrates for the coupling.[11] 
Nevertheless, the facile trifluoroethoxylation of versatile 
(hetero)aryl-chlorides, the most economic, and easily available 
group of haloarenes, remains challenging. Therefore, our 
objective was to develop an operationally simple, reliable and 
scalable catalytic method for the 2,2,2-trifluoroethoxylation of 
chloroarenes, without external base, and thus eliminating the 
necessity of genotoxic Cs2CO3. The applicability of tetravalent 
fluoroalkoxy-borate salts[ 12 ] could offer a solution for this 
approach, considering that the palladium catalyzed C-O bond 
forming reactions of aryl chlorides is possible with borate 
salts.[13] 
After the synthesis of Na[B(OCH2CF3)4], its reactivity was 
studied using 4’-chloroacetophenone as a substrate. To our 
disappointment, the reaction gave only 10 % conversion after 1h 
in DMF, dioxane and acetonitrile (Table 1, entries 1-3) 
supposedly due to the higher stability of the trifluoroethoxy 
borate salts compared to the methoxy analog. We observed that 
tetraalkoxy-borates readily undergo ligand exchange reactions in 
various alcohols, and the formed mixed borate salts proved to 
be more reactive.[14] Taken advantage on the ligand exchange 
around the boron center, we supplemented the solvent 
optimization study with polar, protic solvents. Although 
trifluoroethanol as solvent did not enhance the reaction, to our 
great delight, applying water or other alcohols (entries 5-9) led to 
full conversion of the aryl chloride. However in case of H2O, 
MeOH and IPA, besides the desired product [3a] hydroxyl-, 
methoxy and iso-propoxy-acetophenone [5] was also formed in 
significant amounts (entries 5-7). We thought that steric effects 
might play an important role in the transmetallation step, 
therefore we intended to use bulky alcohols such as tert-butanol 
(tBuOH) and tert-amylalcohol (tAmOH) to facilitate the coupling 
reaction and keep the reaction performing with high selectivity. 
As it was expected, in case of sterically congested tertiary 
alcohol solvents, the formation of unwanted alkyl-aryl ether was 
completely suppressed, and the trifluoroethoxylation occurred  
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Table 1. Solvent optimization study
[a]
  
 
Entry Solvent Conv. 
[%]
[b]
 
Yield[%]
[b] 
(3a) 
Yield[%]
[b] 
(4) 
Yield[%]
[b] 
(5) 
1 DMF 10 10 - - 
2 dioxane 11 11 - - 
3 acetonitrile 10 10 - - 
4 CF3CH2OH 1> 1> - - 
5 H2O 100 32 - 68 
[c]
 
6 MeOH 100 1 - 99 
[d]
 
7 
i
PrOH 100 55 4 41 
[e]
 
8 
t
BuOH 100 100 - - 
9 
t
AmylOH 100 100 - - 
[a] Reaction conditions: 4’-chloroacetophenone (0.1 mmol), Na[B(OCH2CF3)4] 
(0.15 mmol; 1.5 eq.), Pd2dba3 (1 mol%), 
t
BuXPhos (2 mol%), Solvent (0.1 ml), 
100 °C, 1 h. [b] Determined by GC analysis [c] R = OH [d] R = OMe [e] R = 
O
i
Pr  
with 100% conversion in 1 hour under the developed 
reaction conditions (entries 8 and 9). 
With an optimized[15], reliable and reproducible method in 
hand, we turned our attention to the substrate scope of the 
reaction, first examining various substituted aromatic chlorides 
under the optimized reaction conditions [Scheme 2]. The 
functional group tolerance, due to the slightly basic and relatively 
mild conditions, was found to be excellent, as ketone- [3a], 
aldehyde- [3b, 3i], benzyl chloride moiety [3c], ester- [3d, 3f], 
cyano- [3e], nitro- [3g], amide- [3k] , alkyne [3l] and protected 
alcohol- [3m] remained intact, showing a broad spectrum of 
applicability and high efficiency (62-95% yield). Only the very 
electron rich N,N-dimethylamino derivative 3j was obtained in 
lower, 23% yield even after 24 hours. We also examined the 
scalability of the reaction, with the lowest possible catalyst 
loading. In case of 4’-chloroacetophenone the reaction was 
carried out on 10 mmol (2 g) scale without loss of efficiency, in 
the presence of 0.2 mol% Pd2dba3 catalyst and 0.4 mol% 
tBuXPhos ligand the product 3a was obtained in 96% yield. 
Next, we demonstrated the synthetic applicability of the 
transformation with the functionalization of versatile biologically 
relevant, heteroaromatic scaffolds [Scheme 3]. Unsubstituted 4-
chloroquinoline [4a] was converted with excellent efficiency 
(84%), likewise other substituted quinolines [4b-g] also provided 
good yields (69-82% yields), while the relatively moderate result 
(50%) of [4e] can be explained partly by steric hindrance. 
Quinazoline [4h, 4i] and quinoxaline [4j] derivatives, as well as 
substituted pyrazine [4k] were also transformed effectively. Bis-
trifluoroethoxylation of the dichloropyrazine [4l] was also 
performed with excellent yield (85%). In addition to the studied 
N-heterocycles, the functionalization of other heterocyclic 
systems containing nitrogen and sulfur heteroatoms such as 
thienopyridine and thienopyrimidine were also carried out, and  
 
Scheme 2. Preparation of carboaromatic trifluoroethyl-aryl ethers. [a] 1h. [b] 
4h. [c] 24h. [d] Pd2dba3 (2 mol%), 
t
BuXPhos (4 mol%) at 120 °C, 4h. 
the corresponding products [4m] and [4n] were isolated in 26% 
and 62% respectively.  
Providing a further evidence of the method’s utility, we 
elaborated the synthesis of the trifluoroethoxy-analogue of the 
blockbuster drug, Sildenafil (Viagra). Our aim was to replace the 
ethoxy group of the original compound with the trifluoroethoxy 
moiety [Scheme 4]. 
 
 
Scheme 3. 2,2,2-Trifluoroethoxylation of heteroaromatic chlorides. [a] 1h. [b] 
4h. [c] 24h. [d] Pd2dba3 (2.7 mol%), 
t
BuXPhos (5.4 mol%), 24h. [e] 
Na[B(OCH2CF3)4] (1.5 mmol; 3.0 equiv.), Pd2dba3 (2 mol%), 
t
BuXPhos 
(4 mol%), 1h. 
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To reach our goal, first, the sulfonation of 2-
chlorobenzaldehyde was carried out, leading to sulfonic acid 5 in 
66% yield. This product was transformed to the corresponding 
sulfonyl chloride with SOCl2, then the latter was amidated with 
the methylpiperazine, to give 2-chloro-5-((4-methylpiperazin-1-
yl)sulfonyl)benzaldehyde 6 in 46% yield. On this aromatic 
chloride the developed palladium-catalyzed methodology was 
applied using the borate salt to obtain the desired aryl-
trifluoroethyl ether 7 in 73% yield. Following the key coupling, 
the aldehyde was transformed by a Pinnick-oxidation to a 
carboxylic acid intermediate 8. This compound underwent a 
CDI-mediated amidation[ 16 ] to give 9, and a base-catalyzed 
cyclization step to give the desired Sildenafil-analog, 10. 
 
Scheme 4. Synthesis of a Sildenafil analogue. 
Physicochemical and in vitro ADME characterization of 
Sildenafil and 10 were also investigated [Table 2]. In case of 
Sildenafil pKa, logP/D values (entries 1-5) were in strong 
correlation with previously determined parameters[ 17 ]. In the 
comparison study, physicochemical properties showed 
significant differences in pKa values of acidic pyrazolo-
pyrimidine-NH function (entry 2) and in logPOCT-DCE values 
(entry 6). The lower pKa,pyrazolo-pyrimidine-NH and logPOCT-DCE values 
of 10 suggest  weaker intramolecular H-bond between the H-
atom of the acidic NH at pyrazolo-pyrimidine and the O-atom of 
the –OCH2CF3 group. QM and MM calculations indicate that the 
formation of intramolecular NH…OCH2CF3 H-bond is preferred 
both in Sildenafil and in 10 analogue. However, in accordance 
with the reported experimental physicochemical parameters, this 
interaction is slightly weaker in the 10 compound. Proton affinity 
calculations also support the increased acidic character of 
pyrazolo-pyrimidine-NH moiety in 10 [18].  
Although, 10 is slightly more lipophilic than Sildenafil, in 
the in vitro gastrointestinal- and blood-brain barrier-specific 
permeability studies, (entries 7 and 8) the two compounds 
showed the same behaviour. Regarding microsome-derived 
intrinsic clearance values, 10 showed greater metabolic rate in 
human species (entry 9), while there were no significant 
difference in the metabolic clearance, in rat species (entry 11). 
Based on earlier study[19] for metabolic pathway indentification of 
Sildenafil, [20] major microsomal dependent metabolic routes of 
10 was also investigated by LC-MS/MS analytical method. 
Similar to Sildenafil microsomal metabolism, N-demethylated 
(piperazine, M10), N,N-deethylated (piperazine, M9), 
hydroxylated (aliphatic, M6) and M9-demethylated derivatives 
(piperazine, M8A) of 10 were indentificated as major metabolites 
by similarity to MS-derived m/z and elution time of Sildenafil [20]. 
The results justify the differences between HLM- and RLM-
related intrinsic clearance values of the two related compounds. 
 
Table 2. Physico-chemical and in vitro ADME properties of Sildenafil and 10 
Entry Physico-chemical and in 
vitro ADME parameters 
[a]
 
Sildenafil-citrate Sildenafil-CF3
 
(10) 
(in citrate form) 
1 pKa,(piperazine-N) 6.65 (6.78)
[17]
 6.43 
2 pKa,(pyrazolo-pyrimidin-NH) 9.15 (9.12)
[17] 8.58 
3 logPOCT/w 3.07 (3.18)
[17]  3.40 
4 logD7.4/6.5 2.99 / 2.69 3.34 / 3.13 
5 logPDCE/w 4.01 (3.75)
[17]
 3.76 
6 ΔlogPOCT-DCE -0.94 (-0.57)
[17]  -0.36 
7 Pe(cm/s)(PAMPA-GIpH6.5) / 
HIAclass 9.2*10
-6
 / high 5.5*10
-6
 / high 
8 logPe (PAMPA-BBB) / 
est.logBB -4.77 / 0.29 -4.74 / 0.34 
9 HLM Clint (mL/min/kg) 7.7 / low 14.6 / moderate 
10 in vivo human Clplasma  6 (ml/min/kg)
[19]
 - 
11 RLM Clint (mL/min/kg) 172.9 / high 125.6 / high 
12 in vivo male rat Clplasma 48 (ml/min/kg)
[19]
 - 
[a] logPOCT/w and logPDCE/w are partition coefficient in octanol-water and 
dichloroethane-water systems, respectively. logPOCT-DCE is a difference 
between logPOCT/w and logPDCE/w. PAMPA-GIpH6.5 and PAMPA-BBB are 
in vitro non-cell permeability study for gastrointestinal (GI)- and blood-brain 
barrier (BBB)-specific permeation, respectively. HLM and RLM Clint are 
human and rat microsome-derived intrinsic clearances (see in SI) 
In conclusion, we developed an operationally simple 
palladium-catalyzed transformation for the trifluoroethoxylation 
of aryl- and heteroaryl utilizing novel, bench stable, tetravalent 
alkoxy borate salt without the use of external base. The 
applicability of the developed procedure was demonstrated with 
the synthesis of variously substituted aryl- and heteroaryl-2,2,2-
trifluoroethyl ethers, as well as the total synthesis of a fluorinated 
analog of Sildenafil. The physico-chemical properties of 10 
showed slight differences with Sildenafil, including a weaker 
affinity towards intramolecular H-bond formation. The fluorinated 
analog showed enhanced metabolism too, which might not be 
disadvantageous, considering the therapeutic field of Sildenafil. 
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Trifluoroethoxylation of aromatic and 
heteroaromatic chlorides utilizing 
borate-salts 
 
 
A novel palladium catalyzed trifluorethyoxylation of aryl chlorides was developed with the aid of new type of borate based 
trifluoroethoxylating reagent. Beyond the functionalization of various aromatic and heteroaromatic systems, the synthesis of the 
trifluoro analog of Sidenafil (Viagra) was achieved together with the determination of its physicochemical properties. 
 
 
